The No. 1 consumer goods company will acquire Aimmune Therapeutics, a biopharmaceutical company developing and commercializing treatments for food allergies, in a deal valued at $2.6 billion.
The completed transaction introduces Utz as a publicly listed company on the New York Stock Exchange after nearly 100 years as a family-owned business.
In survey after survey S&OP consistently ranks as one of the top three management priorities. Why is it then that many organizations find it extremely difficult to improve their ability to develop a company-wide planning process?
The food and beverage giant announces plans to establish new operating units and category leads supported by a new platform services organization, and a newly aligned workforce.
The Procter & Gamble Company annual results unveils 5% full-year growth, while outlining strategic long-term plans including “delivering strong, balanced growth and value creation.”
